Clinical trial
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
NCT00003170 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00003170 |
|---|---|
| Title | Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer |
| Official title | Phase III Double-Blind Study of Glutamine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Dietary Supplement, Other |
| Interventions | glutamine, placebo |
| Enrollment | 129 |
| Start date | Feb 1, 1998 |
| Primary completion | May 1, 2003 |
| Completion | Jun 1, 2003 |
| First posted | Sep 6, 2004 |
| Last update posted | Jul 14, 2016 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: